Simulations Plus News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.12.24	Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date (Businesswire)
19.11.24	Simulations Plus to Participate in the BTIG Digital Health Forum (Businesswire)
13.11.24	Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables (Businesswire)
06.11.24	Simulations Plus to Participate in the Stephens Annual Investment Conference (Businesswire)
30.10.24	Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations (Businesswire)
09.10.24	Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date (Businesswire)
08.10.24	Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings (Businesswire)
28.08.24	Simulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (Businesswire)
23.08.24	Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions (Businesswire)
01.08.24	Simulations Plus Releases DILIsym® X (Businesswire)
30.07.24	Simulations Plus Releases ADMET Predictor® Version 12 (Businesswire)
25.07.24	Simulations Plus to Participate in KeyBanc’s 25th Annual Technology Leadership Forum (Businesswire)
11.07.24	Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety (Businesswire)
20.06.24	Simulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit (Businesswire)
18.06.24	Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date (Businesswire)
12.06.24	Simulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development Continuum (Businesswire)
22.05.24	Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference (Businesswire)
15.05.24	Simulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software (Businesswire)
04.04.24	U.S. FDA Renews DILIsym® Software Licenses for 7th Year (Businesswire)
20.03.24	Simulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date (Businesswire)
13.03.24	Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum (Businesswire)
05.03.24	Simulations Plus and the University of Bath Awarded New FDA Grant (Businesswire)
15.02.24	Simulations Plus Extends Collaboration with Major Toxicology Research Agency (Businesswire)
13.02.24	Simulations Plus Launches Corporate Development Initiative (Businesswire)
06.02.24	Simulations Plus to Participate in Upcoming Healthcare Conferences (Businesswire)
30.01.24	Simulations Plus Releases GastroPlus® Version 9.9 (Businesswire)
09.01.24	Simulations Plus Embarks on Collaboration with Northeastern University and The TIM Company Through New FDA Grant (Businesswire)
03.01.24	Simulations Plus Announces Leadership Appointments Supporting Commitment to Clients and Driving Growth (Businesswire)
20.12.23	Simulations Plus Announces First Quarter Fiscal Year 2024 Earnings and Conference Call Date (Businesswire)
14.11.23	Simulations Plus Outlines Paths to Win at 2023 Investor Day (Businesswire)
08.11.23	ISoP New Board of Trustees Members Announced (Businesswire)
31.10.23	Simulations Plus to Host Investor Day on Tuesday, November 14th (Businesswire)
11.10.23	Simulations Plus Announces Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call (Businesswire)
21.09.23	Simulations Plus Receives New FDA Grant Award (Businesswire)
07.09.23	Simulations Plus Hosts First-of-its-Kind Virtual Summer Camp for Students and Professors (Businesswire)
24.08.23	Simulations Plus Chief Science Officer Dr. Viera Lukacova Honored as Fellow by the American Association of Pharmaceutical Scientists (AAPS) (Businesswire)
15.08.23	Researchers Use the Simulations Plus DILIsym® Platform to Predict Safety of Combined CBD and VPA Treatment (Businesswire)
13.07.23	Simulations Plus Releases ADMET Predictor® 11 (Businesswire)
21.06.23	Simulations Plus Announces Third Quarter Fiscal Year 2023 Earnings and Conference Call Date (Businesswire)
20.06.23	Simulations Plus Acquires Immunetrics to Expand its Immunology and Oncology Drug Development Capabilities (Businesswire)
10.05.23	Simulations Plus Launches New Integrated Pulmonary Software and Services Package to Streamline Drug Development and Improve Patient Outcomes (Businesswire)
18.04.23	Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses (Businesswire)
30.03.23	MIDD+ 2023 Panelists Discuss How to Increase Gender Equity for Women in Science (Businesswire)
28.03.23	Simulations Plus Enters New Strategic Collaboration to Discover Anticancer Therapies Through Its AI-Driven Drug Design Technology (Businesswire)
21.03.23	Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call (Businesswire)
16.03.23	Simulations Plus to Present at Sidoti March Small-Cap Conference (Businesswire)
15.03.23	Simulations Plus Enters Partnership to Apply AI/ML Technologies to Design Novel Compounds (Businesswire)
09.03.23	Lixoft Adds New Data Formatting and Reporting Modules to MonolixSuite™ in Version 2023R1 (Businesswire)
07.03.23	Simulations Plus to Present at Oppenheimer 33rd Annual Healthcare Conference (Businesswire)
28.02.23	Simulations Plus to Present at Raymond James 44th Annual Institutional Investors Conference (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	137.35	1.40 %	K V
Sonova Hldg	297.30	1.29 %	K V
Logitech Intl	74.86	1.22 %	K V
Nestle	75.22	1.02 %	K V
Alcon	76.32	0.95 %	K V
UBS Group	28.17	-0.67 %	K V
Swiss Re	131.95	-0.68 %	K V
Geberit	533.80	-0.78 %	K V
Lonza Grp	541.40	-0.81 %	K V
Kuehne+Nagel Int	202.60	-1.65 %	K V

Nachrichten zu Simulations Plus IncShs

Aktien Top/Flop

Meistgelesene Nachrichten